Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Personnel

Dr.Evidence® Appoints Ken Kobayashi, MD, FACP to its Medical Strategy Advisory Board

Dr.Evidence is pleased to announce the appointment of Ken Kobayashi, MD, FACP to the MSAB. He joins Chair, Calum MacRae, MB, ChB, PhD, BSc, and members, Michael Klag, MD, MPH, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD.

Dr. Kobayashi has a deep background as a clinician-scientist, regulator, scientific diplomat and drug developer across the US, Europe, Latin America, and Japan/Asia. As a senior executive in top-tier pharmaceutical companies including Pfizer, Daiichi Sankyo, AstraZeneca, Janssen, and Novartis, he has successfully overseen the introduction of more than 28 investigational agents and been directly involved with 60 programs, including in the areas of signal transduction inhibitors, epigenetic modifiers, and inflammation/immunotherapy. His experience also includes roles at the National Cancer Institute and the Food and Drug Administration. Kobayashi received his MD from Northwestern University Medical School, Chicago, IL, and his AB from Washington University, St. Louis, MO.

Dr. Kobayashi commented, "I look forward to collaborating with the distinguished members of the MSAB in helping Dr.Evidence revolutionize the life sciences landscape through innovative technology combined with unrivaled domain expertise."

The MSAB is actively advising Dr.Evidence on meaningful advancements to its AI-enabled technology platform, to support greater efficiency and impact across all phases of the drug development lifecycle, from discovery through commercialization.

"Dr. Kobayashi's extensive experience as a clinician-scientist and his leadership in drug development at global pharmaceutical companies will strengthen and complement the expertise of our MSAB," said Dr.Evidence CEO, Rose Higgins. "I am confident that his strategic guidance will enhance our ability to help life sciences companies achieve their mission of driving better patient outcomes."

Joseph A. Boystak, Dr.Evidence Chairman of the Board, said, "Dr. Kobayashi will be an invaluable addition to the team, playing a pivotal role in shaping Dr.Evidence's strategies for delivering evidence-based insights across the drug development lifecycle."

About Dr.Evidence:

Dr.Evidence is the preeminent evidence-based insights platform for life sciences, enabling teams to identify breakthrough insights grounded in the vast universe of published medical literature, drug labels, regulatory documents, and third-party data. It pushes the boundaries of healthcare technology and allows for new possibilities in science, enabling more informed decision making and faster time-to-market for accelerated impact.


These press releases may also interest you

at 21:15
The retail market in Vietnam is estimated to grow by USD 163.49 billion from 2022 to 2027, growing at a CAGR of 11.4%. The retail market in Vietnam is fragmented owing to the presence of many global and regional companies. A few prominent companies...

at 18:05
At today's Global Citizen Festival, Give Lively, a ground-breaking nonprofit fundraising platform, and Shift4 , the leader in integrated payments and commerce technology, announced a partnership to the significant benefit of nonprofit organizations...

at 14:58
Oksana Chusovitina, a legendary artistic gymnast from Uzbekistan and a symbol of longevity in the sport, has set her sights on success at the Hangzhou Asian Games. "I want to compete in the Asian Games to demonstrate what I can do," the 48-year-old,...

at 11:30
Prepare to experience a laser engraving journey like never before as Monport Laser announces the expansion of its robust after-sales technical support services. With an unwavering dedication to exceeding customer expectations, Monport is now seeking...

at 10:13
Trip.com Group CEO Jane Sun today welcomed Italy's Minister of Tourism, Ms Daniela Santanchè, and her delegation, at the Group's office in Shanghai. Ms. Santanchè delegation included Ms. Erika Guerri, Head of Cabinet, Ms. Tiziana D'Angelo, Consul...

at 10:00
Many Samsung, Huawei, and Android users are switching to iPhones 15 these days, drawn by the allure of Apple's latest offering. However, the tricky part comes when they try to transfer WhatsApp from Android to iPhone 15, says Tenorshare. "Many...

News published on and distributed by: